Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ERP and qEEG Measures Collected in Outpatient Settings as Indices of Disease Progression in Alzheimer's Disease (AD)

NCT02769234 is registered in ClinicalTrials.gov with Neuronetrix, Inc. as lead sponsor.

NCT NCT02769234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02769234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ERP and qEEG Measures Collected in Outpatient Settings as Indices of Disease Progression in Alzheimer's Disease (AD)
Lead sponsor
Neuronetrix, Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
July 31, 2017
Enrollment
75 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease